Edward Bullmore1. 1. Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge CB2 2QQ, UK; GlaxoSmithKline, Immuno-Inflammation Therapeutic Area Unit, Stevenage, UK. Electronic address: etb23@medschl.cam.ac.uk.
Authors: Laszlo Hegedüs; Antonio C Bianco; Jacqueline Jonklaas; Simon H Pearce; Anthony P Weetman; Petros Perros Journal: Nat Rev Endocrinol Date: 2022-01-18 Impact factor: 47.564
Authors: Riccardo De Giorgi; Alice M G Quinton; Shona Waters; Philip J Cowen; Catherine J Harmer Journal: Psychopharmacology (Berl) Date: 2022-05-05 Impact factor: 4.415
Authors: Irina Balan; Laure Aurelian; Kimberly S Williams; Brian Campbell; Rick B Meeker; A Leslie Morrow Journal: Front Immunol Date: 2022-07-29 Impact factor: 8.786
Authors: Dora Polsek; Diana Cash; Mattia Veronese; Katarina Ilic; Tobias C Wood; Milan Milosevic; Svjetlana Kalanj-Bognar; Mary J Morrell; Steve C R Williams; Srecko Gajovic; Guy D Leschziner; Dinko Mitrecic; Ivana Rosenzweig Journal: Sci Rep Date: 2020-07-10 Impact factor: 4.379